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PURPOSE. We assessed whether ocriplasmin (OCP) given to patients with idiopathic macular
hole (IMH) results in an altered plane of vitreoretinal (VR) separation compared to patients
without OCP exposure.
METHODS. A prospective study was done of 12 patients with IMH and vitreomacular adhesion
(VMA) given OCP. Patients in whom the IMH failed to close underwent vitrectomy with
peeling of the internal limiting membrane (ILM). The intraoperative staining pattern of the
ILM using Brilliant Blue G (BBG) and examination of the excised ILM with transmission
electron microscopy (TEM) were compared to results of a matched cohort of 31 patients with
IMH who had not received OCP.
RESULTS. Among 12 patients treated with OCP, VMA release occurred in 7 (58%) and hole
closure was achieved in 3 (25%). Vitrectomy was done on the nine patients without hole
closure. In seven of these nine (78%) the ILM had less than 5% of its vitreous surface covered
in residual material on TEM, which was significantly less than in the control group (5/31, 16%,
P ¼ 0.001). In two OCP patients, large amounts of vitreous side material were present, but
the rim of the hole stained evenly with BBG, suggesting that epiretinal material had avulsed
with VR separation, a pattern not seen in any of the control patients. All patients had IMH
closure after vitrectomy and visual results were not significantly different from the control
group.
CONCLUSIONS. Ocriplasmin facilitates more complete VR separation in patients undergoing
surgery for IMH, although it does not result in more eccentric epiretinal tissue release.
Keywords: ocriplasmin, Brilliant Blue G, Staining, internal limiting membrane, macular hole,
vitrectomy, electron microscopy
Ocriplasmin (OCP) is a recombinantly made moleculecontaining the catalytic domain of the nonspecific serine
protease Plasmin. It is thought to exert its action by catalysing
the cleavage of peptide bonds on the carboxy-terminal side of
lysine and arginine molecules in the adhesion molecules
laminin and fibronectin that bond the cortical vitreous to the
internal limiting membrane (ILM) of the retina.1,2 One of the
proposed advantages of OCP, when given intravitreally to
induce vitreoretinal (VR) separation, is that it results in a
cleaner plane of separation compared to surgically induced or
spontaneous vitreous detachment.3,4 This is based on preclin-
ical animal and postmortem human studies in subjects with
normal physiological VR adhesion.5,6 Ocriplasmin has been
licensed for the treatment of symptomatic vitreomacular
adhesion (VMA) with or without accompanying idiopathic
macular hole (IMH). It is successful in inducing VR separation
in approximately 40% of patients if there is no accompanying
epiretinal membrane (ERM) and results in IMH closure, if
present, in approximately the same proportion.2 It is unknown
if the VR cleavage plane is altered in cases of VMA and IMH
given OCP. This would be of interest as it is well documented
that residual epiretinal tissue commonly is present after
vitrectomy for IMH and its removal is one of the principal
motivations for peeling the ILM.3,7,8 Furthermore, it is possible
that OCP may alter the adhesion of the ILM to the underlying
Mu¨ller cell end plates by its action on laminin and fibronectin
deep to the ILM.
We performed a prospective observational study to ascertain
the plane of VR separation in patients with IMH given OCP, but
who failed to close and who then underwent vitrectomy
surgery. Furthermore, we also evaluated the plane of ILM
separation from the underlying retina and the results of surgery.
METHODS
Consecutive patients undergoing intravitreal injection with
OCP (Jetrea; ThromboGenics, Leuven, Belgium) for idiopathic
IMH of less than 400 lm in minimum linear diameter with VMA
were included in the study. Patients in whom the hole failed to
close at 1 month following injection were offered surgery with
vitrectomy, ILM peeling, and gas. The study followed the tenets
of the Declaration of Helsinki, with approval from the local
institutional review board. Informed consent was obtained
from the subjects after explanation of the nature of the study.
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All patients underwent transconjunctival 25-gauge (25g)
vitrectomy (Constellation; Alcon, Fort Worth, TX, USA) using
wide-field noncontact viewing (Eibos; Haag-Streit, Ko¨nig,
Switzerland) with combined phacoemulsification and intraoc-
ular lens (IOL) implantation if phakic. During surgery the
presence of any vitreoretinal adhesion was assessed using
diluted triamcinolone staining and, in cases where this was
present, posterior hyaloid face separation was achieved with
aspiration.
Brilliant Blue G (BBG, ILM Blue; DORC International,
Zuidland, The Netherlands) was used to stain the macula in
all cases. This is a highly purified preparation of 0.025% BBG
mixed with 4% polyethylene glycol to produce a heavier than
water solution. The dye was refluxed onto the macula retina
using the vitrectomy probe and aspirated off after 5 seconds of
contact time. A macular contact lens was used to view the
peeling procedure. The ILM was peeled using a pinch
technique and Grieshaber DSP 25g end gripping forceps
(Alcon Grieshaber, Schaffhausen, Switzerland) and a peel
radius of approximately 1 disc diameter. In cases where there
was incomplete staining of the ILM with adherent pre-ILM
tissue, an area of ILM that had normal staining was selected and
the peel initiated from there. The pre-ILM tissue and ILM were,
hence, peeled ‘‘en bloc,’’ without the need for a second peel.
All surgeries were video recorded for later analysis of the dye
staining pattern and characteristics as previously described.9
Either 25% SF6 or 20% C2F6 gas was used as a tamponade
agent, and the patients instructed to position face down for at
least 5 hours per day for 3 days. Patients were reviewed at 2
weeks and 3 months postoperatively. Pre- and postoperative
best corrected visual acuity (BCVA) at 3 months following the
last interventional procedure was measured using a standard
Snellen acuity chart and converted to the logMAR scores for
the purposes of statistical analysis.
Patients underwent spectral-domain optical coherence
tomography (SD-OCT) on the Heidelberg Spectralis (Heidel-
berg Engineering, Heidelberg, Germany) immediately before
and 1 and 4 weeks after OCP, and immediately before
vitrectomy and 3 months postoperatively to assess closure. In
repeat scans, the AutoRescan function was used to optimize
scan concordance. The AutoRescan depends on active eye
tracking provided through TruTrack. The eye tracking creates a
detailed retinal map and corrects for eye movements, so that
each follow-up OCT scan is registered and locked to the
baseline scan. The minimum linear diameter (MLD) of the hole
was measured as previously described using the Spectralis
measuring tools.10 The presence or absence of vitreous
attachment to the IMH rim was recorded at all time points
and the presence of any epiretinal tissue noted.
Transmission Electron Microscopy (TEM)
The ILM from the patients was placed and fixed immediately in
2% glutaraldehyde in 0.1 M sodium cacodylate buffer. The ILM
was enrobed in low-melting point agarose (4%) to form a small
block. After secondary fixation in 2% osmium tetroxide, the
samples were dehydrated in graded acetone, embedded in
epoxy resin, and polymerized at 608C. Ultrathin sections (70
nm) were taken at two levels through the block, stained with
uranyl acetate and lead citrate, and viewed on a Philips CM100
transmission electron microscope (Philips/FEI Corporation,
Eindhoven, Holland).
The amount of cellular tissue on the vitreous and retinal
sides of the ILM was quantified using images taken at 37900
magnification from 14 randomly sampled areas of the ILM. To
quantify the amount of debris on each surface of the ILM, a grid
of lines (line length 2 lm) was superimposed on each image.
The number of intercepts between the grid line and retinal or
vitreous surface were counted. Another grid (line length 1 lm)
then was superimposed on each image, and the number of
intercepts between the grid lines and any retinal or vitreous
side tissue were counted. The percentage of surface covered
by cellular tissue was taken as the number of intercepts on
tissue/(number of intercepts on the ILM surface3 2) * 100 as
previously described9 (and see Supplementary Fig. S1).
A ‘‘clean’’ vitreous surface of the ILM was defined as having
less than 5% of the surface covered by residual vitreous or
cellular material (Fig. 1).
The results of the analysis were compared to a group of
patients with IMH less than 400 lm in diameter who had not
been given OCP, but who also had undergone IMH surgery
using an identical technique and ILM sampling procedure.
These eyes were recruited in the immediate 12-month period
before the availability of OCP.
Statistical Analysis
Descriptive and statistical analyses was performed using IBM
SPSS Statistics 21 (IBM, White Plains, NY, USA). Patients’
demographic characteristics, pre- and postoperative variables,
and IMH features are presented in terms of mean, SD, and
range or percentage as appropriate.
Two-sample t-tests were used to compare continuous
variables and associations between noncontinuous variables
were analyzed using the v2 statistic using Fisher’s exact
probability. Statistical significance was considered with a P
value of 0.05 or less.
RESULTS
The study period was from October 2013 to November 2014.
During this time period 12 eyes of 12 patients were treated
with 0.125 mg intravitreal OCP. Vitreomacular adhesion
separation was achieved in 7 of the 12 eyes (58%). In three
of these eyes, macular hole closure occurred (25% of total) and
no further intervention was done. Macular hole closure did not
occur in any eye without VMA release. Baseline features for all
12 eyes are given in Table 1. There were significant differences
in the mean age, MLD, base diameter, and visual acuity
outcome between those with primary closure with OCP and
those without (Table 2). Holes that closed primarily with OCP
had a smaller difference between MLD and base diameter than
those that did not (mean difference 70 [SD 27] vs. 427 [SD
244], lm respectively, P ¼ 0.002).
In the remaining nine eyes, four with and five without VMA
separation, the hole remained open and vitrectomy surgery
was performed. In two of the eyes without complete VMA
separation the width of the VMA decreased slightly from 502 to
460 and 109 to 54 lm (patients 4 and 9, Table 1). In the other
eyes without complete VMA release the extent of VMA was
unchanged.
One patient experienced a macular involving rhegmatoge-
nous retinal detachment five days after OCP injection and had
surgery, consisting of vitrectomy, ILM peeling, laser to
peripheral retinal breaks, and SF6 gas combined with
phacoemulsification and IOL implant at 1 week after injection.
The time period from OCP injection to surgery for the other 8
patients was a median of 6 weeks (range, 4–9 weeks). In four
of the nine cases a greater than 100 lm increase in the MLD
was noted on SD-OCT immediately before surgery with a
proportionately greater increase in base diameter (mean
increase in MLD ¼ 133 lm [SD 106], mean increase in base
diameter¼ 459 lm [SD 345], P¼ 0.007; Fig. 2). The change in
macular hole size did not vary significantly between those with
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and without vitreous separation (P¼ 0.22 for minimum linear
diameter change and P ¼ 0.68 for base diameter change).
The intraoperative staining pattern, and percentage of the
vitreous and retinal sides of the ILM covered by abnormal
tissue (residual cortical vitreous and cellular material on the
vitreous side, Mu¨ller cell fragments on the retinal side) for the
nine patients who underwent surgery for a persistently open
hole are shown in Table 3. Seven of the nine patients had
uniform staining patterns and only tiny fragments of residual
vitreous/cellular material on the vitreous side of the ILM. None
of the patients had a nonstaining rim around the holes; that is,
none of the patients had epiretinal tissue surrounding the
macular hole rim. Two of the nine patients had an unusual area
of positive ILM staining surrounding the hole (i.e., the ILM
immediately surrounding the macular home rim did not have
any epiretinal tissue overlying it) in the presence of large areas
of nonstaining, representing ERM, more eccentrically (Fig. 3).
Both patients had large amounts of vitreal side tissue on TEM,
which appeared as a multilayered cellular membrane with a
layer of vitreous between the cellular material and the ILM.
Examination of the preoperative SD-OCT of these patients
showed subtle ERM without vascular distortion on fundal
photography, and this appearance was unchanged after OCP
(Fig. 4). None of the other patients had evidence of any
epiretinal tissue, either eccentrically or at the site of VMA on
SD-OCT.
A control group of 31 eyes (31 patients) with IMH who had
not received OCP, were used for comparative purposes to the 9
TABLE 1. Clinical Characteristics of All Eyes Given OCP
Number Age Sex
MLD/BD
Before
Injection, lm
Vitreofoveal
Separation
After OCP
Closure
After OCP
MLD/BD
Before
Surgery, lm
BCVA 6 mo
Postoperatively,
logMAR
1 75 Female 312/757 Yes No 644/1561 0.5
2 77 Male 281/687 Yes No 526/1182 0.5
3 73 Male 222/380 Yes No * 0.3
4 75 Female 320/820 No No 471/1607 0.5
5 68 Female 384/980 No No 477/1432 0.8
6 73 Female 80/386 No No 92/389 0.3
7 74 Male 240/412 Yes No 302/660 0.2
8 79 Female 295/602 No No 395/895 0.3
9 74 Female 371/1326 No No 442/1912 0.6
10 66 Female 212/254 Yes Yes NA 0.2
11 68 Female 198/295 Yes Yes NA 0.2
12 69 Female 215/286 Yes Yes NA 0.3
NA, not applicable as hole closed; BD, base diameter.
* Retinal detachment involving fovea occurred 5 days following OCP and, hence, hole dimensions immediately before surgery uncertain.
FIGURE 1. Representative TEM images of ILM. (A, B) Thin layer of adherent vitreous (long arrow) with an overlying cellular membrane (short
arrow). (C, D) An ILM without any residual vitreous side material. *In all images the retinal side of the ILM is marked. Scale bars: 2 lm.
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eyes that failed to close after OCP (Table 4). The mean age of
this group was 73 years (P¼ 0.18) and there were nine males
(P ¼ 0.68). Of the 31 eyes, 10 (32%) had VMA at the time of
vitrectomy compared to 5 of the 9 (55%) in the OCP group (P¼
0.25). The mean duration of symptoms before vitrectomy
surgery was 9 weeks in the control group compared to 11 in
the OCP treated group (P¼0.52). There also was no significant
difference between the two groups for the MLD at baseline. Of
the 31 eyes, 21 (67%) in the control group had a nonstaining
rim compared to 0 of the 9 in the OCP group (P ¼ 0.0003).
There were seven (78%) patients in the OCP group with a
‘‘clean’’ vitreous side of ILM surface compared to five (16%) in
the control group (P ¼ 0.001).
The BCVA at 3 months postoperatively in the OCP treated
eyes was logMAR 0.44 (SD 0.19) and logMAR 0.35 (SD 0.19) in
the control group (P ¼ 0.21).
DISCUSSION
We found, as with preclinical studies on postmortem human
eyes with a normal VR interface given OCP,5,6 that the VR
cleavage plane appears to be altered by OCP in cases where it
has failed to result in IMH closure. The proportion of eyes with
a ‘‘clean’’ ILM after surgery was greater in OCP-treated eyes
than our control eyes. This was the case in eyes with successful
OCP-induced VR separation and those without. This concurs
with the findings of Asami et al.,11 who found that autologous
Plasmin given preoperatively resulted in an improved cleavage
plane in eyes with an attached, but otherwise normal
vitreoretinal interface, regardless of whether vitreous separa-
tion was achieved pre- or intraoperatively. We also found
significantly that none of the OCP-treated eyes had a non-
staining rim (which would indicate epiretinal tissue) around
the IMH, which we have described previously in approximate-
ly 50% of IMH cases.9
There were two eyes where significant amounts of vitreous
and cellular remnants, representing an ERM, were left on the
retina despite OCP. These also had the unusual finding of a rim
of normally staining ILM around the hole, signifying no or
limited vitreous or cellular material in this area despite the
widespread more eccentric epiretinal material, which we have
not seen in any other eyes. Interestingly both eyes had patchy
high signal on the inner retinal surface on the preoperative SD-
OCTs, which was not present on the other cases. Although
there was no bridging traction or retinal distortion, the OCT
appearance most likely represented the epiretinal tissue seen
surgically and histologically. We hypothesize that when the
FIGURE 2. Horizontal line scan SD-OCT images of case number two at baseline before OCP (A), 1 week after OCP (B), 1 month after OCP (C),
immediately before vitrectomy (6 weeks after OCP) (D), and 3 months after vitrectomy (E). Note release of VMA between 1 week and 1 month
following OCP with increase in horizontal hole diameter, particularly base diameter.
TABLE 2. Comparison of Cases With and Without Primary Closure Following OCP
Eyes With Macular Hole Closure
Following OCP, n ¼ 3
Eyes Without Macular Hole Closure
After OCP, n ¼ 9 P
Age, y, mean (SD) 68 (1.5) 74 (3) 0.001
Sex All (100%) female 7 (78%) female, 2 (22%) male 1
Lens status All (100%) phakic 7 (78%) phakic, 2 (22%) pseudophakic 1
Width of VMA, lm, mean (SD) 303 (8) 180 (191) 0.09
MLD, lm, mean (SD) 208 (9) 278 (91) 0.05
Base diameter, lm, mean (SD) 278 (21) 540 (271) 0.02
Final visual outcome, logMAR, mean (SD) 0.23 (0.06) 0.44 (0.19) 0.01
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zone of vitreomacular adhesion in these eyes was forcibly
separated at the time of surgery, the rim of cellular material
around the IMH also separated. This is likely to be related to
weakening of the adhesion between the remaining vitreous
underlying the ERM and ILM by OCP. The more eccentric ERM
remained attached to the retina, relating to the lack of attached
vitreous to provide a tractional separation force, and also its
action as a barrier to diffusion to the OCP. Despite the smaller
molecular weight of OCP compared to plasmin, ERM will limit
its diffusion to the VR interface, reducing its effectivity. It also
is known that some ERMs do not have an intervening layer of
vitreous collagen between them and the ILM, although we did
not find this in our cases.12
It is thought that most macular holes have a phase where
vitreous is attached to the central foveal area with surrounding
VR separation.13 In some cases when the vitreous separates
spontaneously the developing IMH closes, although this is a
rare phenomenon clinically.14 It is interesting to note that in
the Microplasmin for Intravitreous Injection (MIVI) trials, OCP
resulted in a greater hole closure rate than saline in cases
where there was VR release. Ocriplasmin-induced VR separa-
tion from the fovea resulted in IMH closure in 43% of eyes in
which VR separation was induced compared to 25% in the
saline control arm of the MIVI trials.2 Furthermore, even in
cases where there was no VMA release, hole closure still
occurred in 37% of cases compared to 6% in the saline arm
(personal communication, data on file; ThromboGenics) This
would suggest that there is a further mechanism to hole
closure other than VR separation alone. One possibility is that
vitreous liquefaction with OCP reduces the tractional forces on
the retina.15 Our findings suggesting a modified plane of VR
separation compared to spontaneous or surgical separation
around macular holes also may explain this. Even without total
vitreous separation, local VR release may allow hole closure.
Conversely, the fact that four holes did not close despite
complete VR separation and a clean ILM suggests that other
factors must be addressed to achieve hole closure. The ILM
contributes very significantly to the rigidity of the retina and its
removal is known to improve macular hole closure.16 Changes
in retinal morphology also are known to occur with advancing
macular hole formation, such as those recently described by
Woon et al.17 and ascribed to the central fovea having a bistable
structure. We found that the three holes that closed primarily
with OCP were smaller, and the mean age of the patients
younger, than those that did not, both of which have been
identified previously as being positive prognostic factors.2 Also
interestingly, the holes had relatively narrower base diameters
compared to their MLD and this may be a positive prognostic
factor, but larger numbers are needed to clarify this. We also
observed an increase in diameter in all the holes that did not
close after OCP, particularly base diameter. This could relate to
vitreous traction, although we did not find any difference in the
change in size between those with and without vitreous
separation. Alternatively the increase in base diameter could
TABLE 3. Intraoperative Staining Pattern and TEM Findings of Eyes Given OCP
Patient Number
% of ILM With Residual Tissue Observed ERM Visible
Preoperatively
on OCT
Staining Pattern of BBG
Vitreous Side Retinal Side Across Macula Immediately Around IMH Rim
1 2 23  Uniform pos. Pos.
2 1 28  Uniform pos. Pos.
3 0 20  Uniform pos. Pos.
4 4 28  Uniform pos. Pos.
5 72 49 þ Nonstaining Pos.
6 78 28 þ Nonstaining Pos.
7 2 18  Uniform pos. Pos.
8 0 27  Uniform pos. Pos.
9 0 19 Uniform pos. Pos.
FIGURE 3. Intraoperative images of case number six, (A) with wide angle lens and (B) with high magification contact lens in place, showing ILM
after staining using BBG. Note area of positive staining around the macular hole rim with large areas on nonstaining, indicating epiretinal tissue
eccentrically.
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relate to a direct outer retinal effect of OCP, which also could
hinder hole closure despite successful VMA release.18 Recently,
others have noted similar effects on macular hole size and the
occurrence of new subretinal fluid after vitrectomy surgery
with previous OCP use.19,20 We had no cases of nonclosure or
subretinal fluid after vitrectomy surgery. We had one case of
macular off retinal detachment after OCP due to the formation
of three mid peripheral retinal breaks after vitreous separation.
This case underwent successful retinal reattachment surgery
combined with ILM peeling and a good visual outcome. Despite
the increase in macular hole size and retinal detachment case
we found no significant difference in visual acuity outcomes
between our OCP-treated eyes and control eyes, although
numbers are too small to draw any definitive conclusions
regarding the effect of OCP on long-term visual outcome.
We did not find any changes in either the ILM itself or the
cleavage plane of the ILM from its underlying layer of Mu¨ller
cell endplates. The ILM is composed chiefly of type 4 collagen.
Although referenced, but unpublished data, suggests that OCP
may have some activity against type 4 collagen, others have not
found this with Plasmin, and early phase studies with OCP
have shown no changes in human post mortem and feline
ILM.21,22 The exact adhesion mechanisms of ILM to Mu¨ller cells
is uncertain and the lack of any change in ILM adhesion could
have a number of explanations. The adhesion molecules
responsible for ILM are incompletely documented, and the
laminin subtypes and fibronectin isoforms may differ, and have
different susceptibilities to those responsible for VR adhesion.
It also is possible that even if disrupted by OCP the adhesion
molecules could have reformed by the time of vitrectomy
surgery, which was a median of 6 weeks later. It also is possible
that OCP did not diffuse to the sub-ILM space. We observed
subtle ellipsoid changes around the macular hole margin in
some of the patients, but no patient experienced dyschroma-
topsia or symptoms suggestive of more widespread photore-
ceptor dysfunction, as has been described previously, although
we did not perform electrophysiology.23–26
The study has several weaknesses. Larger numbers would
add validity to our findings. We used TEM to quantify the
extent of ILM surface material. Studies using scanning electron
microscopy and flat-mounted specimens may be better at
showing the exact arrangement of the residual vitreous
material. However, we also documented the staining pattern
of ILM-specific dye BBG, which we have shown previously
correlates closely with the extent of pre-ILM material, and
which added relevant topographical detail to our findings. As
controls we used a series of ILMs from patients with macular
holes of less than 400 lm in size; 32% of these had VMA at
baseline compared to all nine OCP-treated eyes that underwent
vitrectomy. However, 50% of the OCP-treated eyes released
VMT following OCP, meaning that the two groups were more
similar in this respect immediately before surgery.
In conclusion, this study suggested that OCP can lead to
more complete VR separation in patients with macular holes
and VMA. This was the case in eyes with OCP-induced VR
separation and in eyes where the vitreous still needed to be
FIGURE 4. Horizontal line scan SD-OCT images of cases five (A) and six (B). Case six has a full-thickness retinal hole on eccentric slice (C). Note
patchy high signal on retinal surface in both cases representing fine ERM.
TABLE 4. Comparison of Eyes Given OCP to Eyes in the Non–OCP-Treated Control Group
Age, y, Mean
(SD, Range)
MLD at Baseline, lm,
Mean (SD, Range)
% Tissue, Mean (SD, Range)
‘‘Clean’’ Vitreous Side
of the ILM, n (%)Retinal Side Vitreous Side
Eyes given OCP, n ¼ 9 74 (3, 68–79) 264 (85, 80–384) 27 (9, 18–49) 18 (31, 0–78) 7 (78%)
Control eyes, n ¼ 31 73 (6, 61–84) 288 (74, 148–399) 25 (8, 13–43) 29 (28, 0–78) 5 (16%)
P 0.14 0.33 0.58 0.35 0.001
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separated at the time of surgery. Persistent VMA after OCP can
occur in cases with ERMs surrounding the zone of VMA, which
can be subtle, but discernible on preoperative SD-OCT. A clean
ILM surface after OCP, however, does not guarantee macular
hole closure and other morphological variants in macular hole
shape and ILM rigidity are likely important.
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